Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Summer;20(3):15-152.
doi: 10.7812/TPP/15-152. Epub 2016 Jul 25.

Recurrence of Epithelioid Hemangioendothelioma during Pregnancy: Case Report and Systematic Review

Affiliations
Case Reports

Recurrence of Epithelioid Hemangioendothelioma during Pregnancy: Case Report and Systematic Review

Michael Mcculloch et al. Perm J. 2016 Summer.

Abstract

Introduction: Epithelioid hemangioendothelioma (EHE) is a family of blood vessel tumors originating in blood vessels, bone, brain, kidney, liver, and lung. EHE is more common in women, and chemotherapy, radiation, and surgery have brought few successes.

Case presentation: We present a case of a 28-year-old woman whose EHE recurred during pregnancy, suggesting hormonal involvement. We conducted a systematic review to provide analysis and interpretation of the potential significance of her disease recurring, with fatal outcome, during pregnancy.

Discussion: Very little research has explored the use of individual hormonal markers. Strongly positive expression of placenta growth factor (PlGF) and 17-beta estradiol receptors have been reported. Expression of PlGF is noteworthy in our case, in that our patient's disease quickly and dramatically flared in the 25th week of pregnancy, near the peak in maternal PlGF production. PlGF binds to vascular endothelial growth factor-1 (VEGF-1), and PlGF may accelerate VEGF-induced angiogenesis. Taken together, these factors may explain our patient's EHE recurrence and rapid flare-up during pregnancy. Treatment of EHE with VEGF inhibition, potentially in combination with other antiangiogenic and tumor-inhibiting therapies such as lenalidomide, thalidomide, sorafenib, and sunitinib, may also hold promise.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Hematoxylin/eosin stain showing epithelioid cells with cytoplasmic vacuoles (magnification ×400).
Figure 2.
Figure 2.
Hematoxylin/eosin stain showing epithelioid cells with cytoplasmic vacuoles (magnification ×600).
Figure 3.
Figure 3.
Immunohistochemical stain positive for vascular marker CD31 (magnification ×600).
Figure 4.
Figure 4.
Immunohistochemical stain positive for vascular marker CD34 (magnification ×600).
Figure 5.
Figure 5.
Computed tomography angiography of the chest, showing stable disease in 2008.
Figure 6.
Figure 6.
Computed tomography angiography of the chest, showing stable disease in 2011.
Figure 7.
Figure 7.
Computed tomography angiography of the chest, following disease recurrence in 2012.
Figure 8.
Figure 8.
Timeline of the patient’s case. CT = computed tomography scan.

Similar articles

Cited by

References

    1. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982 Sep 1;50(5):970–81. doi: 10.1002/1097-0142(19820901)50:5<970::aidcncr2820500527>3.0.co;2-z. . - DOI - PubMed
    1. Salech F, Valderrama S, Nervi B, et al. Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol. 2011 Jan-Mar;10(1):99–102. - PubMed
    1. Lau K, Massad M, Pollak C, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest. 2011 Nov;140(5):1312–8. doi: 10.1378/chest.11-0039. . - DOI - PubMed
    1. Osawa S, Saito A, Shimizu H, Ogawa T, Watanabe M, Tominaga T. A case of intravascular epithelioid hemangioendothelioma occurring 14 years after coil embolization for an extracranial internal carotid artery aneurysm. J Vasc Surg. 2012 Jan;55(1):230–3. doi: 10.1016/j.jvs.2011.06.108. . - DOI - PubMed
    1. Davies KD, Doebele RC. Molecular pathways: ROS1 fusion proteins in cancer. Clin Cancer Res. 2013 Aug 1;19(15):4040–5. doi: 10.1158/1078-0432.ccr-12-2851. . - DOI - PMC - PubMed

LinkOut - more resources